Edition:
India

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

9.27USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$9.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
281,055
52-wk High
$18.90
52-wk Low
$8.67

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.62
Market Cap(Mil.): $863.35
Shares Outstanding(Mil.): 67.71
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates